You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
|
|---|---|
| Published in |
BMC Musculoskeletal Disorders, October 2013
|
| DOI | 10.1186/1471-2474-14-299 |
| Pubmed ID | |
| Authors |
Alfons A den Broeder, Noortje van Herwaarden, Aatke van der Maas, Frank HJ van den Hoogen, Johannes W Bijlsma, Ronald F van Vollenhoven, Bart JF van den Bemt |
| Abstract |
Preliminary, mostly uncontrolled studies suggest that dose reduction or discontinuation of tumour necrosis factor blockers can be achieved in a relevant proportion of patients with RA without loss of disease control. However, long term safety, cost effectiveness and feasibility in clinical practice remain uncertain. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 50% |
| Germany | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 116 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 16% |
| Researcher | 14 | 12% |
| Student > Master | 14 | 12% |
| Student > Bachelor | 10 | 8% |
| Other | 8 | 7% |
| Other | 25 | 21% |
| Unknown | 28 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 47% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 8% |
| Psychology | 5 | 4% |
| Nursing and Health Professions | 4 | 3% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 5 | 4% |
| Unknown | 36 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2015.
All research outputs
#12,768,271
of 22,727,570 outputs
Outputs from BMC Musculoskeletal Disorders
#1,708
of 4,032 outputs
Outputs of similar age
#105,705
of 211,997 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#27
of 80 outputs
Altmetric has tracked 22,727,570 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,032 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,997 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.